← FDA DRUG APPROVALS
FDA ANDA · ANDA062422
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER
Sponsor: BAXTER HLTHCARE
APPLICATION
ANDA062422
TYPE
ANDA
ORIGINAL APPROVAL
1984-01-31
LATEST ACTION
1991-07-16
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINERDiscontinued
CEPHALOTHIN SODIUM EQ 40MG BASE/ML · INJECTABLE · INJECTION
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINERDiscontinued
CEPHALOTHIN SODIUM EQ 40MG BASE/ML · INJECTABLE · INJECTION
CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINERDiscontinued
CEPHALOTHIN SODIUM EQ 40MG BASE/ML · INJECTABLE · INJECTION
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINERDiscontinued
CEPHALOTHIN SODIUM EQ 20MG BASE/ML · INJECTABLE · INJECTION
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINERDiscontinued
CEPHALOTHIN SODIUM EQ 20MG BASE/ML · INJECTABLE · INJECTION
CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINERDiscontinued
CEPHALOTHIN SODIUM EQ 20MG BASE/ML · INJECTABLE · INJECTION
Approval history
1991-07-16Labeling · Supplement 12AP
1984-01-31OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.